Product Information

FYCOMPA 12 MG TABLET is a brand product labeled by Catalyst Pharmaceuticals, Inc., priced at $39.0776 per EA under NDC 69616028230. Its NADAC has been published 133 times since Feb 7, 2024.

FDA first approved this application on Oct 22, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

FYCOMPA 12 MG TABLET

perampanel
$39.0776per EA
DEA Schedule CIII

Strength

12 mg/1

NDC

69616028230

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

PERAMPANEL

Approval Type

New Drug (NDA)

FDA Application

NDA202834

FDA Approved

10/22/2012

TE Code

AB

On Market Since

1/2/2024

Pharmacological Classes

AMPA Receptor Antagonists
Cytochrome P450 2C8 Inhibitors
Cytochrome P450 3A4 Inhibitors
Noncompetitive AMPA Glutamate Receptor Antagonist
UGT1A9 Inhibitors
UGT2B7 Inhibitors

Price Statistics

The NADAC for FYCOMPA 12 MG TABLET has been published 133 times since Feb 7, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$39.0776 per EA
All-time high$39.4499 (May 15, 2024)
All-time low$39.0776 (Aug 19, 2026)
52-week high$39.2446
52-week low$39.0776
Median price$39.2397
Average price$39.2387
Largest weekly change-0.8% (May 22, 2024)
Weeks tracked133
Tracking sinceFeb 7, 2024

Price History

1W

-0.1%

1M

-0.1%

3M

-0.3%

6M

-0.3%

1Y

-0.4%

3Y

N/A

5Y

N/A

All

-0.9%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of FYCOMPA 12 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for FYCOMPA 12 MG TABLET, manufactured by Catalyst Pharmaceuticals, Inc., is $39.0776 per EA (NDC 69616028230), effective Aug 19, 2026.

How has the price of FYCOMPA 12 MG TABLET changed over time?

Over the history we have for it, the NADAC for FYCOMPA 12 MG TABLET has held within roughly two percent of its current level. It has been tracked across 133 weekly CMS publications since Feb 7, 2024.

What are the highest and lowest recorded NADAC prices for FYCOMPA 12 MG TABLET?

Since Feb 7, 2024, the NADAC for FYCOMPA 12 MG TABLET has ranged from a low of $39.0776 (Aug 19, 2026) to a high of $39.4499 (May 15, 2024), with a median of $39.2397 per EA.

Are there cheaper alternatives to FYCOMPA 12 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FYCOMPA 12 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures FYCOMPA 12 MG TABLET?

FYCOMPA 12 MG TABLET (NDC 69616028230) is labeled by Catalyst Pharmaceuticals, Inc., and CMS classifies it as a brand product.